普罗阿吉奥 (ProAgio) 是一种新型的整合蛋白αvβ3向性细胞毒素,抑制瘤生长并重新编程PDAC微环境
bioRxiv : the preprint server for biology
|February 6, 2026
概括
通过减少缺氧和增强抗瘤免疫力,ProAgio与GPH治疗相结合显著改善胰腺癌瘤微环境. 这种新的组合显示了未来胰腺管腺癌 (PDAC) 治疗策略的前景.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 医疗成像医学成像
背景情况:
- 胰腺管道腺癌 (PDAC) 具有密集,缺氧和免疫抑制的瘤微环境 (TME).
- 综合素αvβ3表达细胞,包括内皮细胞和癌症相关纤维细胞 (CAF),是PDAC TME的关键贡献者.
- 普罗阿吉奥是一种新型细胞毒素,向整合素αvβ3,并且GPH (gemcitabine,paricalcitol,化) 影响PDAC TME.
研究的目的:
- 研究ProAgio和GPH联合治疗对PDAC的协同效应.
- 评估这种组合对瘤微环境的影响,包括缺氧,免疫细胞透和树突正常化.
- 在临床前模型和患者中使用动态对比增强MRI (DCE-MRI) 评估瘤 perfusion.
主要方法:
- 使用患者衍生异种移植 (PDX) 和PDAC的正极形模型.
- 采用免疫组织化学来评估缺氧,上皮-介质细胞过渡 (EMT) 和血管生成.
- 进行多参数流细胞测量用于免疫细胞分析和DCE-MRI用于瘤 perfusion 分析.
主要成果:
- 通过消耗整合素β3表达细胞,ProAgio增强了GPH的增长抑制作用,导致ECM重塑,减少血管泄漏,改善缺氧,并逆转EMT.
- 在ProAgio治疗后,DCE-MRI在小鼠和患者中显示瘤 perfusion 的显著增加.
- 组合疗法显著增加了γδ T 细胞,NKT 细胞,CD4+ 功效 T 细胞和M1-样巨细胞的透,同时减少了myCAFs.
结论:
- 通过向整合素αvβ3,ProAgio有效调节PDAC TME,增强输液,减少缺氧,逆转EMT,减轻免疫抑制.
- 普罗阿吉奥和GPH的组合表明治疗效果和免疫调节效益的增强.
- 需要进行进一步的临床试验,以评估ProAgio在增强PDAC的GPH治疗中的作用.
相关概念视频
The Tumor Microenvironment
7.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.8K
Integrins
5.5K
Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
5.5K
Activation of Integrins
5.1K
Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
5.1K
Introduction to Nuclear Reprogramming
2.3K
Nuclear reprogramming is the process of switching gene expression of one cell type to that of another cell type, usually from a differentiated cell state to an undifferentiated cell state. Differentiation occurs during processes such as development and morphogenesis, tissue regeneration, and malignancy. Cells can also be artificially induced to reprogram their gene expression by techniques such as nuclear transfer, induced pluripotency, and cell fusion. Such techniques have many applications in...
2.3K
Methods of Nuclear Reprogramming
2.2K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
2.2K
Population Growth
28.6K
Population size is dynamic, increasing with birth rates and immigration, and decreasing with death rates and emigration. In ideal conditions with unlimited resources, populations can increase exponentially, which plots as a J-shaped growth rate curve of population size against time. This type of curve is characteristic of newly-introduced invasive species, or populations that have suffered catastrophic declines and are rebounding.
28.6K


